(Q34494173)

English

Grazoprevir, Elbasvir, and Ribavirin for Chronic Hepatitis C Virus Genotype 1 Infection After Failure of Pegylated Interferon and Ribavirin With an Earlier-Generation Protease Inhibitor: Final 24-Week Results From C-SALVAGE.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26371152%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Grazoprevir, Elbasvir, and Ribavirin for Chronic Hepatitis C Virus Genotype 1 Infection After Failure of Pegylated Interferon and Ribavirin With an Earlier-Generation Protease Inhibitor: Final 24-Week Results From C-SALVAGE (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26371152%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1 reference

ChEBI release 2020-05-28

1 reference

based on heuristic

inferred from title

Hepatitis C virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

chronic hepatitis C

1 reference

based on heuristic

inferred from title

pegylated interferon

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

Jose Luis Calleja-Panero

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26371152%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1

object named as

Maria Buti

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26371152%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

author name string

Stuart C Gordon

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26371152%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Eli Zuckerman

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26371152%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Eric Lawitz

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26371152%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Harald Hofer

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26371152%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Christopher Gilbert

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26371152%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

John Palcza

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26371152%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Anita Y M Howe

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26371152%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Mark J DiNubile

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26371152%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Michael N Robertson

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26371152%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Janice Wahl

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26371152%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Eliav Barr

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26371152%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Xavier Forns

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26371152%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

language of work or name

0 references

publication date

14 September 2015

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26371152%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Clinical Infectious Diseases

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26371152%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

62

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26371152%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26371152%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

32-36

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26371152%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Resistance-associated variants in chronic hepatitis C patients treated with protease inhibitors

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV722

21 January 2018

Analysis of boceprevir resistance associated amino acid variants (RAVs) in two phase 3 boceprevir clinical studies

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV722

21 January 2018

Evolution of treatment-emergent resistant variants in telaprevir phase 3 clinical trials

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV722

21 January 2018

Clinical relevance of HCV antiviral drug resistance

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV722

21 January 2018

Utility of detection of telaprevir-resistant variants for prediction of efficacy of treatment of hepatitis C virus genotype 1 infection

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV722

21 January 2018

Grazoprevir and elbasvir plus ribavirin for chronic HCV genotype-1 infection after failure of combination therapy containing a direct-acting antiviral agent

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV722

21 January 2018

Recommendations for standardized nomenclature and definitions of viral response in trials of hepatitis C virus investigational agents

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV722

21 January 2018

Concordance of sustained virological response 4, 12, and 24 weeks post-treatment with sofosbuvir-containing regimens for hepatitis C virus

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV722

21 January 2018

Amplification and sequencing of the hepatitis C virus NS3/4A protease and the NS5B polymerase regions for genotypic resistance detection of clinical isolates of subtypes 1a and 1b.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV722

21 January 2018

Grazoprevir-Elbasvir Combination Therapy for Treatment-Naive Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection: A Randomized Trial

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV722

21 January 2018

Identifiers

10.1093/CID/CIV722

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26371152%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26371152%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34494173&oldid=1624051320"